ScreenerHero

VITR Vitrolife AB (publ)

STO · SE · Healthcare · Medical Devices · vitrolife.com
89.65SEK-2.34%Mkt Cap: 1.16B $P/E: —

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap1.16B USD
Enterprise Value1.26B USD
Revenue (TTM)324.26M USD
Gross Profit191.02M USD
Net Income (TTM)-479.41M USD
Revenue/Share25.03 SEK
Last Price89.65 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.1K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011205202
Valuation
P/E (Trailing)—
P/E (Forward)19.09
PEG2.02
EV/EBITDA13.37
EV/Revenue3.90
P/S3.67
P/B1.53
EPS (TTM)-36.80
EPS (Forward)4.81
52W Range
84.008% of range153.50
52W High153.50 SEK
52W Low84.00 SEK
Profitability
Gross Margin58.05%
Oper. Margin23.10%
EBITDA Margin29.14%
Profit Margin-145.70%
ROE-63.49%
ROA-45.06%
Growth
Revenue Growth-1.60%
Earnings Growth28.70%
Cash Flow & Leverage
Operating CF60.74M USD
CapEx (TTM)23.63M USD
FCF Margin16.31%
FCF Yield4.55%
Net Debt74.42M USD
Net Debt/EBITDA0.79
Balance Sheet
Debt/Equity0.20
Current Ratio3.64
Quick Ratio2.76
Book Value/Sh60.04 SEK
Cash/Share6.08 SEK
Dividends
Fwd Div Rate1.10 SEK
Trail. Div Rate1.10 SEK
Div. Yield1.20%
5Y Avg Yield0.43%
Payout Ratio33.85%
Ex-Div DateMay 6, 2026
Pay Date—
Splits
Last Split5:1
Split DateMay 17, 2018
Analyst Consensus
Rating—
Target (Mean)129.60 SEK
Upside (mean)+44.6%
Target Range95.00 SEK – 155.00 SEK
95.00+44.6% to mean155.00
# Analysts5
Ownership
Shares Out.135.45M
Float73.71M
Insiders29.72%
Institutions58.59%
Technical
SMA 5091.49 (-2.0%)
SMA 20099.20 (-9.6%)
Beta1.72
S&P 52W Chg14.58%
Avg Vol (30d)165.29K
Avg Vol (10d)107.76K
Technical Indicators
RSI (14)47.7
MACD0.3028
MACD Signal0.3613
MACD Hist.-0.0585
BB Upper95.05 SEK
BB Middle92.31 SEK
BB Lower89.58 SEK
BB Width5.93%
ATR (14)2.354 SEK
Vol Ratio (20d)0.53x